valrubicin

pharmaceutical drug
rdfs:label
"valrubicin"@en
skos:altLabel
"(8S, 10S)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 8²-valerate"@en
"2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate"@en
"Valstar"@en
schema:description
"pharmaceutical drug"@en
schema:dateModified "2026-11-04T09:24:08+00:00"^^xsd:dateTime
schema:version 2564634625
wikibase:identifiers 25
wikibase:sitelinks 6
wikibase:statements 41
p:P11089 wd:statement/Q7912593-5C0EFE4B-BCC3-4906-8E76-98D6A81CEDA9
p:P11198 wd:statement/Q7912593-05C7057D-9A68-4157-8517-B85D149009F3
p:P11199 wd:statement/Q7912593-E631B05A-DCD5-4E44-AE78-1DD107E51582
p:P117 wd:statement/Q7912593-94e47369-4957-ed30-4e77-84218b07141f
p:P1748 wd:statement/Q7912593-055F13A7-F575-4513-91A0-187CC47B216E
p:P2017 wd:statement/Q7912593-1ED60B8A-1B5A-4081-A64E-D2761AA14D06
p:P2062 wd:statement/Q7912593-0FCC74E7-0430-4A82-B1BD-B4BC4DE03BD4
p:P2067 wd:statement/Q7912593-57250BD3-FB76-4C28-89BF-97E5D71C28E4
p:P2115 wd:statement/Q7912593-6A62BEB6-93C6-464E-AAA4-81F6897F65FB
p:P2175 wd:statement/Q7912593-27154218-E552-4B62-B501-E66878C4E9F8
p:P231 wd:statement/Q7912593-49AFF5F8-1239-45EF-9CE4-00139101334E
p:P232 wd:statement/Q7912593-ACAAD932-5AD8-4335-AB46-3C677763AFE8
p:P233 wd:statement/Q7912593-88BB0268-AAFA-4C4B-834E-896C581E8411
p:P234 wd:statement/Q7912593-A72A2030-CF21-4CEA-9DFD-67B12B82A26B
p:P235 wd:statement/Q7912593-4D7C5C77-8D08-48E1-9B74-5F2D4C1C1F46
p:P2566 wd:statement/Q7912593-13572468-2468-1357-eca9-bdf024681357
p:P267 wd:statement/Q7912593-8A27F3E8-AD90-4A62-A5D5-ADCB73C1AFBF
p:P274 wd:statement/Q7912593-9B33377B-E279-4762-A7ED-6837BEA44267
p:P279 wd:statement/Q7912593-90BB9396-F4FC-4400-90C2-F02478704B8C
p:P2840 wd:statement/Q7912593-DB9B65B2-7C51-4CDE-8D50-84272EDDF7C0
p:P2868 wd:statement/Q7912593-301EEBCD-B3A9-4F50-A07C-5FAA2D6CAC0E
wd:statement/Q7912593-CF8611E1-AC1C-4350-A932-8C0474E1A4D1
wd:statement/Q7912593-EBCFAD23-71FF-4FCA-BB1B-2C1F24D8546E
p:P2877 wd:statement/Q7912593-044152A8-233B-446A-80B8-0B2D3C3C311D
p:P31 wd:statement/Q7912593-53F582C2-8F16-490A-AAC8-E9449C0499D9
p:P3117 wd:statement/Q7912593-6D7BE5C9-5A33-4A79-949D-78D3E42CE25C
p:P3345 wd:statement/Q7912593-229BCE39-13A0-455C-B849-101223ABDE51
p:P3489 wd:statement/Q7912593-812362C3-7B77-4CE4-8299-5E2DBC59CDDD
p:P366 wd:statement/Q7912593-C9DE1725-1AFB-4E7F-B4A1-90FD1787F5B8
p:P373 wd:statement/Q7912593-689B4028-313E-4072-909B-9B7E971B0481
p:P3780 wd:statement/Q7912593-F73ED013-680F-4A96-98E7-B29C058C0F6C
p:P486 wd:statement/Q7912593-D86530BF-A0C4-461E-B667-C6D68AC7F3CB
p:P592 wd:statement/Q7912593-5EBC2F6E-E923-422B-BE1C-C3DF01D79E9B
p:P6366 wd:statement/Q7912593-58C1DF20-ADC2-42C4-A402-EA22FEFC3B95
p:P646 wd:statement/Q7912593-2CA5E94F-9678-492F-9146-05D4277FC270
p:P652 wd:statement/Q7912593-77E8CB81-3C74-4621-BFE2-742B2AAD3BD3
p:P661 wd:statement/Q7912593-BFD663AA-980A-45A6-84E2-363377A38CF4
p:P662 wd:statement/Q7912593-4840EE46-7596-4DB0-9945-0C7A598CA1D0
p:P683 wd:statement/Q7912593-81E21F27-2156-44A6-A466-77D8D2EF779D
p:P715 wd:statement/Q7912593-46339914-DA3A-4B81-9DE8-D1E276712730
p:P8494 wd:statement/Q7912593-D0969477-EF53-4734-9857-CC0A11BE743C
p:direct-normalized/P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000148597>
p:direct-normalized/P486 <http://id.nlm.nih.gov/mesh/C016163>
p:direct-normalized/P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL20225>
p:direct-normalized/P6366 <https://makg.org/entity/2778368998>
p:direct-normalized/P661 <http://rdf.chemspider.com/38088>
p:direct-normalized/P662 <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID454216>
p:direct-normalized/P683 <http://purl.obolibrary.org/obo/CHEBI_135876>
wdt:P11089 "124816"
wdt:P11198 "2805"
wdt:P11199 "PD014197"
wdt:P117 <http://commons.wikimedia.org/wiki/Special:FilePath/Valrubicin.svg>
wdt:P1748 "C1340"
wdt:P2017 "CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C3=C(C1)C(O)=C4C(=O)C5=CC=CC(OC)=C5C(=O)C4=C3O"
wdt:P2062 "7288"
wdt:P2067 723.213875^^xsd:decimal
wdt:P2115 "N0000148597"
wdt:P2175 bladder cancer
wdt:P231 "56124-62-0"
wdt:P232 "680-664-1"
wdt:P233 "CCCCC(=O)OCC(=O)C1(CC(C2=C(C3=C(C(=C2C1)O)C(=O)C4=C(C3=O)C(=CC=C4)OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O"
wdt:P234 "InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22-,27+,33-/m0/s1"
wdt:P235 "ZOCKGBMQLCSHFP-KQRAQHLDSA-N"
wdt:P2566 "100.205.793"
wdt:P267 "L01DB09"
wdt:P274 "C₃₄H₃₆F₃NO₁₃"
wdt:P279 2-Oxo-2-[2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(2,2,2-trifluoro-1-hydroxyethylidene)amino]hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate
wdt:P2840 "246131"
wdt:P2868 topoisomerase inhibitor
antineoplastic
topoisomerase II inhibitor
wdt:P2877 "12824"
wdt:P31 type of chemical entity
wdt:P3117 "DTXSID9046497"
wdt:P3345 "31435"
wdt:P3489 US pregnancy category C
wdt:P366 medication
wdt:P373 "Valrubicin"
wdt:P3780 Valstar
wdt:P486 "C016163"
wdt:P592 "CHEMBL20225"
wdt:P6366 "2778368998"
wdt:P646 "/m/07cqhf"
wdt:P652 "2C6NUM6878"
wdt:P661 "38088"
wdt:P662 "454216"
wdt:P683 "135876"
wdt:P715 "DB00385"
wdt:P8494 "DTXCID7026497"
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata